An incurable #cancer meets a promising new treatment target in this Science Translational Medicine study. Researchers used Chromium #singlecell as part of a comprehensive approach to reveal answers for how multiple myeloma arises. This remarkable work ID’d biomarkers within B-cell subpopulations, revealed regulatory mechanisms, uncovered a novel target for CAR T-cell therapy…and kicked off a Phase I clinical trial. Congratulations to the team! https://lnkd.in/gU4BbsiR
10x Genomics
Biotechnology Research
Pleasanton, California 268,560 followers
Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬
About us
Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.
- Website
-
http://10xgenomics.com
External link for 10x Genomics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Pleasanton, California
- Type
- Public Company
- Founded
- 2012
Locations
-
Primary
Get directions
6230 Stoneridge Mall Rd
Pleasanton, California 94588, US
Employees at 10x Genomics
Updates
-
A recent benchmarking study highlighted in Nature Communications championed Xenium for consistently delivering higher transcript counts per gene compared to other platforms, without sacrificing specificity—a result of its robust signal amplification and sensitive probe design. Xenium’s reliability and technical sensitivity make it a top choice for spatial transcriptomic studies with FFPE samples. Read more: https://lnkd.in/eEpMMR2v
-
That’s a wrap! We are honored to be part of the ASTRA consortium to build an APAC-region 2000+ pan-cancer atlas at spatial resolution. Thank you to the amazing attendees. We loved talking to you about our #Xenium In Situ platform, and we're excited to continue partnering with Garvan Institute of Medical Research and The University of Tokyo on this project and beyond!
-
-
Talking single cell and spatial biology with the nation’s leading neuroscientists at #SfN25? Mindblowing. Catch the highlights!
Back on the West Coast for the Society for Neuroscience 2025 Annual Meeting this week — in a surprisingly rainy San Diego! The photos below highlight just a few of the things happening at the conference, including: 1. Joshua Talboom presenting how neuroscientists are using 10x Genomics single-cell and spatial platforms — highlighting Flex and Multiome in Parkinson’s disease research and Xenium in Alzheimer’s disease research. 2. Strong engagement at the 10x booth, with Joe Tolar, PhD, Christine Kao, Tu Luu, John Hoang, Marco Serra, Shauna Clark, Egon Ranghini, PhD, and Joshua Talboom connecting with researchers. 3. Marco Serra sharing his Visium HD 3' poster with current and future neuroscientists. 4. Weston Stauffer walking attendees through his Xenium Protein poster.
-
-
“[combining single cell and spatial] will increase the amount of biological insights that we get and, potentially, discovery potential because we'll be able to find markers that are circulating in the immune system at the same time as we really look in situ at the tissue structure that's being affected in the disease.” — Sarah Carl, Scailyte Wondering how to combine single cell and spatial technologies in your experiment? Reach out to us at https://bit.ly/4rauTCy
-
How will the ASTRA consortium’s pan-#cancer spatial atlas shape the future of precision #oncology and drug discovery? By giving the research community unmatched #singlecell #spatialtranscriptomics insights into 2,000+ samples across 10 cancer types, all powered by the #Xenium platform. Read the press release now and see how the Garvan Institute of Medical Research, The University of Tokyo, and 10x Genomics are leading the way: https://lnkd.in/gYnujSKT
-
-
Fragile samples, samples rich in neutrophils and granulocytes, biobanked #FFPE tissues? The VIB Single Cell Core Facility is running it all for their customers and finding success with Flex. Hear from core head Dr. Niels Vandamme in this blog on the powerful advantages of Flex and how his team found a unique solution to reduce costs. https://bit.ly/4oD8j3Q
-
-
What an eye-opening week at #AMPath2025. We talked single cell and spatial biology with the nation’s leading molecular pathologists. Check out the highlights!
Just wrapped up a really fun, albeit cold for this San Diego guy, week at AMP 2025. Here are some of the highlights in pictures: 10x Genomics Corporate Workshops showcasing Xenium to 1) Identify major cell types in dermatomyositis by Kevin Wei, Harvard Medical School and 2) Annotating fibroblast subtypes in IBD by Susan Westmoreland, Abbvie; 3) Innovation Spotlight on Xenium Protein by 10x's own Cheyenne Christopherson and Manavi Abrol; 4) hanging out and making a new friend with Curt Akers at the GenomeWeb/Foundation Medicine kick off event (thanks Drew Thornley for the invite) and my first up close look at the new Axelios system...congrats to Mitu Chaudhary and the whole Roche Sequencing USA team over there!
-
-
Enlightening insights from 10x CTO Michael Schnall-Levin in R&D World about how 10x Genomics and Anthropic are partnering to make single cell data analysis more impactful and accessible. Explore how this collaboration is accelerating discovery and democratizing access to crucial technology.
In my latest piece for R&D World, 10x Genomics CTO Michael Schnall-Levin explains why plugging Anthropic’s Claude into 10x’s cloud stack can help turn non-trivial, code-heavy workflows into something many more scientists can run themselves. We talk about how: “The last mile goes from ‘non-trivial work, requiring scarce expertise’ to something a much broader set of people can do themselves.”
-
-
Going to Neuroscience 2025? Visit us at Booth 805 and discover how multiomic single cell and spatial approaches can illuminate the fundamental biology driving complex, multifactorial neurodegenerative, psychiatric, and neurodevelopmental diseases. Don’t miss our Product Theater on Sunday, November 16th, plus our posters on neurogenesis and glioblastomata on Tuesday, November 18th and Wednesday, November 19th. Let our experts partner with you to advance your scientific discoveries. https://bit.ly/3X26wsQ #SfN25
-